Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line.
about
Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cellsBMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer.Insulin-like growth factor binding protein-3 mediates interleukin-24-induced apoptosis through inhibition of the mTOR pathway in prostate cancer.Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid.Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell lines.Zoledronic acid and irradiation in oral squamous cell carcinoma.Zoledronic acid but not somatostatin analogs exerts anti-tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration-resistant prostate cancer.Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines.Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells.Bisphosphonates and cancer: what opportunities from nanotechnology?Apoptosis-mediated cytotoxic effects of ibandronic acid on hormone- and drug-refractory prostate cancer cells and human breast cancer cells.Zoledronic acid inhibits proliferation and impairs migration and invasion through downregulating VEGF and MMPs expression in human nasopharyngeal carcinoma cells.
P2860
Q35043887-745EA148-1A3B-46D0-AA62-93EDEEBDE7FAQ35691501-87A827EE-9702-40FC-BA27-FCCC4F00A493Q36094078-BE2D71DD-80C5-4F24-94DE-2085546E1A6FQ36459367-7C9EE587-7F4F-4A0F-BE83-1551BC83AC2AQ38949883-F6C76178-84AA-4EBA-84C6-8A91345EEB27Q38971985-4ACDE64D-6873-4807-87F1-0C01CF2B0F92Q39274492-031B5F3D-A68B-49A4-813A-58021E90E0EBQ39709311-A8BAA827-E7F3-4A6D-96FC-624864302386Q39843822-6FCCB751-1127-4D46-ABE4-6C7CF825B201Q41829362-BA1959F6-8A30-4544-A838-D1DE8153ACA4Q42751429-6B20AF73-5904-4595-9B95-E9AA9336C731Q44240872-81F46AD4-5FF3-4A9C-9DC2-20553D82B3A0
P2860
Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Zoledronic acid increases doce ...... prostate carcinoma cell line.
@en
Zoledronic acid increases doce ...... prostate carcinoma cell line.
@nl
type
label
Zoledronic acid increases doce ...... prostate carcinoma cell line.
@en
Zoledronic acid increases doce ...... prostate carcinoma cell line.
@nl
prefLabel
Zoledronic acid increases doce ...... prostate carcinoma cell line.
@en
Zoledronic acid increases doce ...... prostate carcinoma cell line.
@nl
P2093
P2860
P50
P356
P1476
Zoledronic acid increases doce ...... prostate carcinoma cell line.
@en
P2093
Dino Amadori
Giovanni Brigliadori
Rosella Silvestrini
Silvia Carloni
Wainer Zoli
P2860
P2888
P356
10.1186/1479-5876-6-43
P577
2008-08-08T00:00:00Z
P5875
P6179
1015252656